In the intricate world of pharmaceutical development, specific chemical intermediates serve as the bedrock for innovation. (2R)-3,3-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid, identified by its CAS number 124655-17-0, is one such compound. As a protected form of D-tert-leucine, it is highly sought after by researchers and manufacturers for its utility in synthesizing novel therapeutic agents. If you are seeking to purchase this critical component, understanding its role and sourcing options is essential.

The significance of CAS 124655-17-0 stems from its precise chemical structure and purity, typically offered at 95%min. This compound is a cornerstone in the creation of primary amino acid derivatives. These derivatives are often investigated for their potential to act as anticonvulsants or to offer relief from neuropathic pain, addressing critical unmet medical needs. For businesses involved in drug discovery, securing a reliable supply of this intermediate is a strategic imperative. Exploring options to buy from specialized manufacturers in China can offer both quality and cost-effectiveness.

Procurement managers and research scientists often require detailed specifications and consistent quality when sourcing intermediates like this. The molecular formula C11H21NO4 and molecular weight of 231.28900 provide key identification points, but the real value lies in its application. Its use in creating complex chiral molecules means that purity and stereochemical integrity are paramount. When you are looking to purchase, ensure your supplier can provide comprehensive Certificates of Analysis (CoA) that verify these critical parameters.

The global market for pharmaceutical intermediates is competitive, and China has emerged as a leading manufacturing hub. By partnering with a reputable manufacturer in China for CAS 124655-17-0, you can benefit from economies of scale and specialized production capabilities. This ensures not only competitive pricing for your bulk purchase but also access to a consistent supply chain that can support your long-term development pipeline. Exploring options to 'buy pharmaceutical intermediate' from established suppliers is a smart approach.

In conclusion, (2R)-3,3-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid is more than just a chemical compound; it's an enabler of pharmaceutical progress. Its role in developing treatments for neurological conditions highlights its importance. For organizations looking to buy this essential intermediate, focusing on quality, reliability, and cost-effective sourcing from expert manufacturers is the pathway to success.